21Shares files for Injective ETF amid growing institutional interest

Key Takeaways

• 21Shares has filed for a new ETF focusing on Injective, a blockchain protocol designed for global finance infrastructure.
• The filing highlights the growing institutional interest in integrating digital assets into traditional finance portfolios.

Share this article

21Shares, a major issuer of crypto-focused exchange-traded products, filed today for a new ETF targeting Injective, a blockchain protocol positioned as infrastructure for global finance with features like high-performance consensus and native financial primitives.

The filing represents another expansion of institutional crypto investment products as traditional finance continues integrating digital assets. 21Shares recently expanded listings to UK retail investors on major exchanges.

The company has been actively introducing new exchange-traded products for various digital assets, including those focused on decentralized computing and artificial intelligence. 21Shares has collaborated with foundations and exchanges to launch endorsed products, such as those tied to meme coins and scalable Web3 architectures.

The move signals broader integration of digital assets into mainstream portfolios as entities like 21Shares work to simplify access to blockchain ecosystems through regulated investment vehicles.